Heart Failure Management in 2023: A Pharmacotherapy- and Lifestyle-Focused Comparison of Current International Guidelines
This review examines the pharmacotherapy and lifestyle recommendations of the most recent iterations of the Canadian Cardiovascular Society (CCS) / Canadian Heart Failure Society (CHFS), the European Society of Cardiology (ESC), and the American Heart Association (AHA) / American College of Cardiolo...
Main Authors: | Blair J. MacDonald, BA, PharmD, Sean A. Virani, MD, MSc, MPH, Shelley Zieroth, MD, Ricky Turgeon, BSc(Pharm), ACPR, PharmD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | CJC Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589790X23001233 |
Similar Items
-
Decisional Needs and Patient Treatment Preferences for Heart Failure Medications: A Scoping Review
by: Blair J. MacDonald, BA, PharmD, et al.
Published: (2023-02-01) -
Direct Oral Anticoagulant Use Early After Cardiac Surgery: A Retrospective Cohort Study
by: Jung-Jin Wu, PharmD, ACPR, et al.
Published: (2024-02-01) -
Comparison of Preventive Cardiovascular Pharmacotherapy in Surgical vs Percutaneous Coronary Revascularization
by: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR, et al.
Published: (2019-11-01) -
Chronic Amiodarone Use and the Risk of Cancer: A Systematic Review and Meta-analysis
by: Lauren A. Siemers, et al.
Published: (2021-01-01) -
Use of Guideline-Directed Medical Therapy in Patients Aged 80 Years or Older With Heart Failure With Reduced Ejection Fraction
by: Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR, et al.
Published: (2023-04-01)